FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and is intended for the diagnosis of myelodysplastic syndrome. In the mononuclear cell fractions of patients, the expression of VEGF-A, VEGFR1 and VEGFR2 was determined. If the level of VEGF-A expression exceeds 4 times or more, the expression of the VEGFR1 gene is 1.5 times or more and the expression of the VEGFR2 gene is 25 times or more compared to the norm, the presence of myelodysplastic syndrome is judged.
EFFECT: invention provides an increase in the accuracy of diagnosis of the myelodysplastic syndrome.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR ASYMPTOMATIC CELIAC DISEASE IN ADULTS | 2020 |
|
RU2747523C1 |
| METHOD OF THE TREATMENT OF POLYNEUROPATHY ASSOCIATED WITH GLUTEN-SENSITIVE CELIAC DISEASE | 2022 |
|
RU2800847C1 |
| METHOD FOR ASSESSING EFFICACY OF NUTRITIONAL SUPPORT ACCOMPANYING ULCERATIVE COLITIS | 2013 |
|
RU2552319C1 |
| METHOD OF DIAGNOSING THE SEVERITY OF IRRITABLE BOWEL SYNDROME | 2017 |
|
RU2668496C2 |
| METHOD FOR DETERMINING RISK OF ISCHEMIC HEART DISEASE | 2013 |
|
RU2532361C1 |
| METHOD FOR PREVENTING TUBERCULOSIS IN INFLAMMATORY INTESTINAL DISEASES | 2018 |
|
RU2712943C1 |
| METHOD FOR DIAGNOSING SEVERE PSEUDOMEMBRANOUS COLITIS IN PATIENTS AFTER CORONAVIRUS INFECTION | 2022 |
|
RU2786752C1 |
| METHOD FOR TREATING INFLAMMATORY INTESTINAL DISEASES | 2018 |
|
RU2690949C1 |
| METHOD OF TREATMENT HEPATIC CIRRHOSIS OF VARIOUS ETIOLOGY | 2015 |
|
RU2593007C1 |
| DIAGNOSTIC TECHNIQUE FOR DRUG-INDUCED LIVER INJURY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2018 |
|
RU2695021C1 |
